Acquired demyelinating and inflammatory neuropathies encompass a number of acute and
chronic autoimmune conditions characterized by variable degrees of clinical involvement …

Autoimmune-mediated disorders belong to the main causes of neuropathies worldwide.
During recent years much progress has been achieved in the understanding of the …

The Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy are
the most extensively studied immune-mediated neuropathies. Randomized treatment …

Inflammatory neuropathies are a heterogeneous group of rare diseases of the peripheral
nervous system that include acute and chronic diseases, such as Guillain-Barré syndrome …

This paper reviews recent treatment strategies of immune mediated neuropathies, in
particular it includes data regarding Guillain-Barré syndrome (GBS), chronic inflammatory …

Immune-mediated neuropathies are a heterogeneous group of peripheral nerve disorders,
which are classified by time course, clinical pattern, affected nerves and pathological …

Chronic dysimmune neuropathies are less common than Guillain–Barré syndrome (GBS).
They mainly comprise chronic idiopathic demyelinating polyneuropathy (CIDP), multifocal …

Experimental models have suggested potential new treatments for human inflammatory
neuropathy, but current practice is largely based on empirical trials. Evidence from …

This review describes the progress made in preparing Cochrane systematic reviews of
randomized controlled trials for Guillain–Barré syndrome (GBS), chronic inflammatory …

Guillain‐Barré syndrome (GBS) and chronic inflammatory demyelinating poly‐(radiculo)
neuropathy (CIDP) are immune‐mediated disorders with a variable duration of progression …